Giulio Preta

Dr. Giulio Preta

Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio 7, LT-10257 Vilnius, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2015 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
GPGiulio Preta
Giulio Preta
James CroninJames Cronin
James Cronin
ISIain Martin Sheldon
Iain Martin Sheldon
Dynamin is a GTPase protein that is essential for membrane fission during clathrin-mediated endocytosis in eukaryotic cells. Dynasore is a GTPase inhibitor that rapidly and reversibly inhibits dynamin activity, which prevents endocytosis. However, comparison between cells treated with dynasore and RNA interference of genes encoding dynamin, reveals evidence that dynasore reduces labile cholesterol in the plasma membrane, and disrupts lipid raft organization, in a dynamin-independent manner. To explore the role of dynamin it is important to use multiple dynamin inhibitors, alongside the use of dynamin mutants and RNA interference targeting genes encoding dynamin. On the other hand, dynasore provides an interesting tool to explore the regulation of cholesterol in plasma membranes.

9 February 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
ASAna L. Santos
Ana L. Santos
GPGiulio Preta
Giulio Preta

2 September 2020 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
GPGiulio Preta
Giulio Preta
Modulation of membrane lipid composition and organization is currently developing as an effective therapeutic strategy against a wide range of diseases, including cancer. This field, known as membrane-lipid therapy, has risen from new discoveries on the complex organization of lipids and between lipids and proteins in the plasma membranes. Membrane microdomains present in the membrane of all eukaryotic cells, known as lipid rafts, have been recognized as an important concentrating platform for protein receptors involved in the regulation of intracellular signaling, apoptosis, redox balance and immune response. The difference in lipid composition between the cellular membranes of healthy cells and tumor cells allows for the development of novel therapies based on targeting membrane lipids in cancer cells to increase sensitivity to chemotherapeutic agents and consequently defeat multidrug resistance. In the current manuscript strategies based on influencing cholesterol/sphingolipids content will be presented together with innovative ones, more focused in changing biophysical properties of the membrane bilayer without affecting the composition of its constituents.

30 December 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GPGiulio Preta
Giulio Preta
VLVirginia Lotti
Virginia Lotti
James CroninJames Cronin
James Cronin
ISIain Martin Sheldon
Iain Martin Sheldon
The virulence of many Gram‐positive bacteria depends on cholesterol‐dependent cytolysins (CDCs), which form pores in eukaryotic cell plasma membranes. Pyolysin (PLO) from Trueperella pyogenes provided a unique opportunity to explore cellular responses to CDCs because it does not require thiol activation. Sublytic concentrations of PLO stimulated phosphorylation of MAPK ERK and p38 in primary stromal cells, and induced autophagy as determined by protein light‐chain 3B cleavage. Although, inhibitors of MAPK or autophagy did not affect PLO‐induced cytolysis. However, 10 μM 3‐hydroxynaphthalene‐2‐carboxylic acid‐(3,4‐dihydroxybenzylidene)‐hydrazide (Dynasore), a dynamin guanosine 5'‐triphosphatase inhibitor, protected stromal cells against PLO‐induced cytolysis as determined by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay (85 ± 17% versus 50 ± 9% cell viability), measuring extracellular ATP, and kinetic assays. This was a generalized mechanism because Dynasore also protected HeLa cells against streptolysin O. Furthermore, the effect was reversible, with stromal cell sensitivity to PLO restored within 30 minutes of Dynasore removal. The protective effect of Dynasore was not conferred by dynamin inhibition, induction of ERK phosphorylation, or Dynasore binding to PLO. Rather, Dynasore reduced cellular cholesterol and disrupted plasma membrane lipid rafts, similar to positive control methyl‐β‐cyclodextrin. Dynasore is a tractable tool to explore the complexity of cholesterol homeostasis in eukaryotic cells and to develop strategies to counter CDCs.—Preta, G., Lotti, V., Cronin, J. G., and Sheldon, I. M. Protective role of the dynamin inhibitor Dynasore against the cholesterol‐dependent cytolysin of Trueperella pyogenes. FASEB J. 29, 1516‐1528 (2015). www.fasebj.org

6 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SGSholeem Griffin
Sholeem Griffin
GPGiulio Preta
Giulio Preta
ISIain Martin Sheldon
Iain Martin Sheldon
Animal health depends on the ability of immune cells to kill invading pathogens, and on the resilience of tissues to tolerate the presence of pathogens. Trueperella pyogenes causes tissue pathology in many mammals by secreting a cholesterol-dependent cytolysin, pyolysin (PLO), which targets stromal cells. Cellular cholesterol is derived from squalene, which is synthesized via the mevalonate pathway enzymes, including HMGCR, FDPS and FDFT1. The present study tested the hypothesis that inhibiting enzymes in the mevalonate pathway to reduce cellular cholesterol increases the resilience of stromal cells to PLO. We first verified that depleting cellular cholesterol with methyl-β-cyclodextrin increased the resilience of stromal cells to PLO. We then used siRNA to deplete mevalonate pathway enzyme gene expression, and used pharmaceutical inhibitors, atorvastatin, alendronate or zaragozic acid to inhibit the activity of HMGCR, FDPS and FDFT1, respectively. These approaches successfully reduced cellular cholesterol abundance, but mevalonate pathway enzymes did not affect cellular resilience equally. Inhibiting FDFT1 was most effective, with zaragozic acid reducing the impact of PLO on cell viability. The present study provides evidence that inhibiting FDFT1 increases stromal cell resilience to a cholesterol-dependent cytolysin.

1 February 2019 in Biochimie
Verified
Journal Article
Closed access
TPTadas Penkauskas
Tadas Penkauskas
GPGiulio Preta
Giulio Preta